The worldwide medical sensors market is mainly propelled by the rising demand for these devices across diagnostic & therapeutic industries. It stood around USD 9.5 billion in 2015 and is likely to attain a size of nearly USD 19 billion ...Read More »
The vascular graft market was worth about USD 1.9 billion in 2014. It is projected to reach around USD 3.6 billion by 2022. Cardiovascular diseases and technological advances in tissue engineered vascular grafts are its drivers. Rising healthcare costs and ...Read More »
The U.S. medical device outsourcing market generated around USD 13.3 billion in 2014. The major market driver is demand for healthcare instruments & cost control. Additionally, connected advantages like decreased production costs and concentration on core proficiencies are predicted to ...Read More »
The North America home healthcare market was worth USD 757 million in 2014. It is projected to grow lucratively, at around 10% CAGR during 2015 to 2022 (forecast period). This can be attributed to geriatrics population and resulting chronic ailments. ...Read More »
The hemostasis and tissue sealing agents market was about USD 3.4 billion in 2014. Hemostats & sealants are healthcare instruments that stop hemorrhages & bleeding. These conditions may arise from surgical practices & wounds. The market is predicted to experience ...Read More »
The Latin America flow cytometry market was valued around USD 250 million in 2014. It will be worth about USD 565 million by 2022. Rising chronic diseases (e.g. HIV, leukemia, etc) necessitate toxicity tests. This acts as a market driver.
The ...Read More »
3D bioprinting is the manufacture of biological organs; with cell function & viability preserved. 3D bioprinters use bio-ink; creating a cellular structure layer by layer, finally resulting in a functioning living tissue or organ.
For Market Research Report on “3D Bioprinting ...Read More »
Fluorescent in situ hybridization (FISH) is a technique that helps visualize the location of a particular gene or DNA sequence in a person’s genome. This information assists a scientist in identifying specific chromosomal alterations that could have caused specific genetic ...Read More »
The epigenetic market had approximately USD 4 billion value by size in 2014 and is estimated to rise at 19% CAGR in the future. The major drive to the epigenetics market is the rising occurrence of cancer. Epigenetics has initiated ...Read More »
The artificial vital organs and medical bionics market was valued USD 23 billion in 2014. Rising health conditions like cirrhosis, respiratory ailments, liver & kidney failures, etc. will aid future growth in the market. The geriatric populace also drives demand.
For ...Read More »